Table 4.
Sociodemographic and Behavioral Differences in Achieving Each Study Milestone From Eligibility Through Completion of Enrollmenta, Understanding New Infections Through Targeted Epidemiology, United States, 2017–2018
| Characteristic |
Eligible Contacts (n = 27,358) of All Eligible (n = 37,143)b |
Completed Enrollment Survey (n = 10,687c) of All Sent (n = 26,000) |
HIV-Negative Test Result (n = 7,956 d ) of Sent Test Kits (n = 10,685) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | % | χ 2 | P Value | No. | % | χ 2 | P Value | No. | % | χ 2 | P Value | |
| Age group, years | 67.10 | <0.001 | 137.6 | <0.001 | 19.91 | 0.001 | ||||||
| <18 | 506 | 71.4 | 114 | 40.3 | 80 | 84.8 | ||||||
| 18–24 | 8,297 | 71.9 | 2,832 | 36.1 | 2040 | 72.0 | ||||||
| 25–34 | 6,384 | 75.4 | 2,512 | 41.0 | 1849 | 73.5 | ||||||
| 35–49 | 9,636 | 75.1 | 4,100 | 44.3 | 3,119 | 76.0 | ||||||
| ≥50 | 2,535 | 70.3 | 1,129 | 45.4 | 868 | 77.0 | ||||||
| Race/ethnicity | 20.09 | <0.001 | 205.17 | <0.001 | 130.67 | <0.001 | ||||||
| Black | 3,982 | 73.3 | 1,266 | 34.5 | 868 | 68.6 | ||||||
| Latino | 6,514 | 73.9 | 2,270 | 38.0 | 1,570 | 69.2 | ||||||
| White | 11,616 | 73.1 | 5,195 | 45.6 | 4,103 | 79.0 | ||||||
| Multiracial | 3,886 | 75.9 | 1,364 | 37.8 | 954 | 69.9 | ||||||
| Other | 1,360 | 71.9 | 592 | 44.3 | 462 | 77.9 | ||||||
| Region | 17.67 | 0.003 | 20.41 | 0.001 | 12.68 | 0.03 | ||||||
| Northeast | 4,838 | 72.8 | 1806 | 39.9 | 1,338 | 74.1 | ||||||
| Midwest | 4,670 | 73.3 | 1936 | 43.3 | 1,460 | 75.4 | ||||||
| South | 9,787 | 73.8 | 3,780 | 40.7 | 2,806 | 74.2 | ||||||
| West | 7,739 | 74.4 | 3,061 | 41.3 | 2,289 | 74.8 | ||||||
| Puerto Rico | 316 | 73.0 | 103 | 34.8 | 62 | 60.2 | ||||||
| Military overseas or invalid zip code | 7 | 14.0 | 0 | 00.0 | 0 | 00.0 | ||||||
| Sexual identity | 118.05 | <0.001 | 42.67 | <0.001 | 16.80 | <0.001 | ||||||
| Gay | 21,576 | 74.7 | 8,660 | 42.1 | 6,505 | 75.1 | ||||||
| Queer | 731 | 78.6 | 288 | 41.6 | 223 | 77.4 | ||||||
| Bisexual | 5,040 | 68.8 | 1739 | 36.9 | 1,228 | 70.6 | ||||||
| Relationship status | 2.16 | 0.09 | 1.25 | 0.26 | 0.09 | 0.76 | ||||||
| Single | 20,031 | 73.9 | 7,799 | 40.9 | 5,800 | 74.4 | ||||||
| Partnered | 7,327 | 73.0 | 2,888 | 41.7 | 2,156 | 74.7 | ||||||
| Insurance status | 144.13 | <0.001 | 118.99 | <0.001 | 85.74 | <0.001 | ||||||
| No insurance | 6,892 | 76.8 | 2,356 | 36.5 | 1,626 | 69.0 | ||||||
| Private insurance | 15,914 | 71.4 | 6,701 | 43.8 | 5,190 | 77.5 | ||||||
| Public insurance | 4,552 | 77.3 | 1,630 | 41.1 | 1,140 | 69.9 | ||||||
| PrEP status | 80.40 | <0.001 | 8.38 | 0.02 | 2.08 | 0.35 | ||||||
| Currently on PrEP | 1,268 | 79.8 | 533 | 43.5 | 410 | 76.9 | ||||||
| Previously on PrEP | 2,640 | 78.4 | 1,109 | 43.1 | 817 | 73.7 | ||||||
| Never taken PrEP | 23,450 | 72.9 | 9,045 | 41.1 | 6,729 | 74.4 | ||||||
| Most recent HIV test | 121.01 | <0.001 | 216.21 | <0.001 | 32.37 | <0.001 | ||||||
| Within the past 6 months | 16,260 | 72.0 | 6,747 | 42.7 | 5,086 | 75.4 | ||||||
| Within the past 7–12 months | 4,554 | 74.1 | 2036 | 45.6 | 1,550 | 76.1 | ||||||
| Over a year before | 3,878 | 79.5 | 1,235 | 35.7 | 857 | 69.4 | ||||||
| “I’ve never been tested” | 2,666 | 75.2 | 669 | 29.7 | 463 | 69.2 | ||||||
| Recent STI, past 6 months | 4.26 | 0.04 | 6.49 | 0.01 | 5.26 | 0.02 | ||||||
| No | 22,969 | 73.5 | 9,037 | 41.4 | 6,765 | 74.9 | ||||||
| Yes | 4,389 | 74.7 | 1,650 | 39.3 | 1,191 | 72.2 | ||||||
| Drug use, past 6 months | 259.66 | <0.001 | 41.57 | <0.001 | 61.89 | <0.001 | ||||||
| No | 21,527 | 71.9 | 8,614 | 42.1 | 6,553 | 76.1 | ||||||
| Yes | 5,831 | 81.2 | 2073 | 37.3 | 1,403 | 67.7 | ||||||
Abbreviations: HIV, human immunodeficiency virus; PrEP, preexposure prophylaxis; STI, sexually transmitted infection.
a Completion of enrollment was defined as returning an HIV-negative sample.
b Six eligible participants were excluded from analysis due to missing data.
c Four eligible participants were excluded from analysis due to missing data.
d One enrolled participant was excluded from analysis due to missing data.